Seer (NASDAQ:SEER) CFO David Horn Sells 7,309 Shares

Seer, Inc. (NASDAQ:SEER) CFO David Horn sold 7,309 shares of Seer stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $2.03, for a total transaction of $14,837.27. Following the completion of the transaction, the chief financial officer directly owned 486,650 shares in the company, valued at approximately $987,899.50. The trade was a 1.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Seer Stock Up 1.5%

NASDAQ:SEER opened at $2.05 on Thursday. The firm has a market capitalization of $112.71 million, a P/E ratio of -1.68 and a beta of 1.56. The company has a fifty day moving average of $1.98 and a 200 day moving average of $1.89. Seer, Inc. has a 52 week low of $1.55 and a 52 week high of $2.41.

Seer (NASDAQ:SEER) last announced its quarterly earnings results on Tuesday, August 11th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.04). The firm had revenue of $3.10 million during the quarter, compared to the consensus estimate of $3.55 million. Seer had a negative return on equity of 27.23% and a negative net margin of 478.05%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Marquette Asset Management LLC bought a new stake in shares of Seer during the 2nd quarter valued at about $103,000. NewEdge Advisors LLC purchased a new position in shares of Seer during the first quarter valued at about $132,000. Rangeley Capital LLC raised its stake in Seer by 821.5% in the first quarter. Rangeley Capital LLC now owns 184,302 shares of the company’s stock worth $310,000 after buying an additional 164,302 shares in the last quarter. Corient Private Wealth LLC bought a new position in Seer in the fourth quarter worth about $116,000. Finally, Quadrature Capital Ltd purchased a new stake in Seer in the fourth quarter worth about $101,000. 75.20% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on SEER. Canaccord Genuity Group began coverage on Seer in a report on Monday, May 4th. They set a “buy” rating and a $4.00 price target on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of Seer in a report on Friday, July 17th. Two investment analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Seer has a consensus rating of “Buy” and an average target price of $4.00.

About Seer

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.